Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016)
- PMID: 28541262
- DOI: 10.1097/MPG.0000000000001594
Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016)
Abstract
Background: Because of the changing epidemiology of Helicobacter pylori infection and low efficacy of currently recommended therapies, an update of the European Society for Paediatric Gastroenterology Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition recommendations for the diagnosis and management of H pylori infection in children and adolescents is required.
Methods: A systematic review of the literature (time period: 2009-2014) was performed. Representatives of both societies evaluated the quality of evidence using GRADE (Grading of Recommendation Assessment, Development, and Evaluation) to formulate recommendations, which were voted upon and finalized using a Delphi process and face-to-face meeting.
Results: The consensus group recommended that invasive diagnostic testing for H pylori be performed only when treatment will be offered if tests are positive. To reach the aim of a 90% eradication rate with initial therapy, antibiotics should be tailored according to susceptibility testing. Therapy should be administered for 14 days, emphasizing strict adherence. Clarithromycin-containing regimens should be restricted to children infected with susceptible strains. When antibiotic susceptibility profiles are not known, high-dose triple therapy with proton pump inhibitor, amoxicillin, and metronidazole for 14 days or bismuth-based quadruple therapy is recommended. Success of therapy should be monitored after 4 to 8 weeks by reliable noninvasive tests.
Conclusions: The primary goal of clinical investigation is to identify the cause of upper gastrointestinal symptoms rather than H pylori infection. Therefore, we recommend against a test and treat strategy. Decreasing eradication rates with previously recommended treatments call for changes to first-line therapies and broader availability of culture or molecular-based testing to tailor treatment to the individual child.
Similar articles
-
The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.Pediatr Int. 2020 Dec;62(12):1315-1331. doi: 10.1111/ped.14388. Pediatr Int. 2020. PMID: 32657507 Free PMC article.
-
[Adaptation to the reality of Latin America of the NASPGHAN/ESPGHAN 2016 Guidelines on the Diagnosis, Prevention and Treatment of Helicobacter pylori Infection in Pediatrics].Rev Chil Pediatr. 2020 Oct;91(5):809-827. doi: 10.32641/rchped.vi91i5.2579. Rev Chil Pediatr. 2020. PMID: 33399648 Spanish.
-
Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children.J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):230-43. doi: 10.1097/MPG.0b013e3182227e90. J Pediatr Gastroenterol Nutr. 2011. PMID: 21558964
-
Eradication Rate of Helicobacter pylori on the US-Mexico Border Using the Urea Breath Test.South Med J. 2018 Jan;111(1):51-55. doi: 10.14423/SMJ.0000000000000747. South Med J. 2018. PMID: 29298370
-
The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.Eur J Gastroenterol Hepatol. 2017 May;29(5):552-559. doi: 10.1097/MEG.0000000000000822. Eur J Gastroenterol Hepatol. 2017. PMID: 28350745
Cited by
-
Helicobacter Pylori infection in children with inflammatory bowel disease: a prospective multicenter study.BMC Pediatr. 2024 Jun 29;24(1):417. doi: 10.1186/s12887-024-04902-z. BMC Pediatr. 2024. PMID: 38951792 Free PMC article.
-
Adapted first-line treatment of Helicobacter pylori infection in Algerian children.Ann Gastroenterol. 2019 Jan-Feb;32(1):60-66. doi: 10.20524/aog.2018.0317. Epub 2018 Oct 3. Ann Gastroenterol. 2019. PMID: 30598593 Free PMC article.
-
Comparison of Helicobacter pylori stool antigen, salivary IgG, serum IgG, and serum IgM as diagnostic markers of H. pylori infection in children.Iran J Microbiol. 2019 Jun;11(3):206-211. Iran J Microbiol. 2019. PMID: 31523403 Free PMC article.
-
How and when investigating and treating Helicobacter pylori infection in children.Acta Biomed. 2018 Dec 17;89(8-S):65-71. doi: 10.23750/abm.v89i8-S.7893. Acta Biomed. 2018. PMID: 30561420 Free PMC article.
-
Management of Helicobacter pylori infection in paediatric patients in Europe.Infection. 2023 Jun;51(3):797-798. doi: 10.1007/s15010-022-01969-7. Epub 2022 Dec 22. Infection. 2023. PMID: 36547865 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous